Moderna is developing an mRNA-based vaccine for norovirus, now in Phase 3 trials, with hopes of approval by 2026 to combat the highly contagious stomach virus.
Sayaka Blickenderfer is a medical and science editor and writer with more than 10 years of experience. She edits and prepares scientific manuscripts and grant proposals for submission. Intestinal ...
Intestinal parasitic infections are a significant health concern for individuals living with HIV/AIDS. These infections can exacerbate the complications associated with HIV, leading to increased ...
Norovirus is often colloquially referred to as the “stomach flu,” however ... to the historical period for peak norovirus infections. Symptoms usually develop 12 to 48 hours after infection.
What you may think is a common stomach ache brought on ... each year — you need to know the symptoms and treatments for this sometimes-fatal infection. The Centers for Disease Controls and ...